Stay updated on Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.

Latest updates to the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedVersion 3.3.3 (2025-12-19) adds Contacts/Locations and Study Status. The preceding Version 3.3.2 (2025-10-06) removes HHS Vulnerability Disclosure.SummaryDifference0.5%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedThe page history shows a new revision entry, updating from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedThe top banner about government funding and operating status has been removed.SummaryDifference0.5%

- Check66 days agoChange DetectedOnly cosmetic UI/layout adjustments to the Record History page are evident; there are no new or removed history entries or changes to study data. The version list and underlying content remain effectively unchanged.SummaryDifference0.1%

- Check88 days agoChange DetectedAdded a new date entry and a new study status/contacts/locations section; removed an older dated item. This signals updated status, contacts, and locations with a newer timestamp.SummaryDifference1.0%

- Check95 days agoChange DetectedMajor change: page now includes a government funding and operating status notice and a new version tag (v3.2.0). Minor or metadata-only changes were removed (v3.1.0 deletion).SummaryDifference10%

Stay in the know with updates to Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combinations in Muscle Invasive Bladder Cancer Clinical Trial page.